Medicine for treating doxorubicin-induced cardiotoxic injury and application
The invention provides a medicine for treating doxorubicin-induced cardiotoxic injury and application, and relates to the technical field of biological medicine. The invention provides application of a reagent for interfering expression of circular RNAcirc-ZNF609 in myocardial tissue in preparation...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XIAO JUNJIE WANG LIJUN SHEN KETING QI WEITONG ZHU LIYUN |
| description | The invention provides a medicine for treating doxorubicin-induced cardiotoxic injury and application, and relates to the technical field of biological medicine. The invention provides application of a reagent for interfering expression of circular RNAcirc-ZNF609 in myocardial tissue in preparation of a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury, the reagent or the medicine can deliver a gene sequence of circ-ZNF609shRNA which is artificially designed into the myocardial tissue based on AAV virus, and the reagent or the medicine can be used for preparing a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury. The application has the effects of inhibiting apoptosis of myocardial cells, improving the systolic function of the heart and resisting doxorubicin-induced cardiac toxic injury by inhibiting apoptosis of the circular RNAcirc-ZNF609 in myocardial tissues and interfering expression of the circular RNAcirc-ZNF609 in the myocardial tissues.
本发明提供了 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114504658A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114504658A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114504658A3</originalsourceid><addsrcrecordid>eNqNizEKwkAQAK-xEPUP6wMCBhOxlaBYqJV9WPc2YSXsHpc7iL9XwQdYTTEzc3e5shcSZegsQoqMSbQHb5PF_PiaQtRnYg-E0Yslm4RA9JnjC1A9YAiD0GczXbpZh8PIqx8Xbn063ptzwcFaHgMSK6e2uZVlVW-qXb0_bP9p3u_sNoo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Medicine for treating doxorubicin-induced cardiotoxic injury and application</title><source>esp@cenet</source><creator>XIAO JUNJIE ; WANG LIJUN ; SHEN KETING ; QI WEITONG ; ZHU LIYUN</creator><creatorcontrib>XIAO JUNJIE ; WANG LIJUN ; SHEN KETING ; QI WEITONG ; ZHU LIYUN</creatorcontrib><description>The invention provides a medicine for treating doxorubicin-induced cardiotoxic injury and application, and relates to the technical field of biological medicine. The invention provides application of a reagent for interfering expression of circular RNAcirc-ZNF609 in myocardial tissue in preparation of a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury, the reagent or the medicine can deliver a gene sequence of circ-ZNF609shRNA which is artificially designed into the myocardial tissue based on AAV virus, and the reagent or the medicine can be used for preparing a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury. The application has the effects of inhibiting apoptosis of myocardial cells, improving the systolic function of the heart and resisting doxorubicin-induced cardiac toxic injury by inhibiting apoptosis of the circular RNAcirc-ZNF609 in myocardial tissues and interfering expression of the circular RNAcirc-ZNF609 in the myocardial tissues.
本发明提供了</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220517&DB=EPODOC&CC=CN&NR=114504658A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220517&DB=EPODOC&CC=CN&NR=114504658A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XIAO JUNJIE</creatorcontrib><creatorcontrib>WANG LIJUN</creatorcontrib><creatorcontrib>SHEN KETING</creatorcontrib><creatorcontrib>QI WEITONG</creatorcontrib><creatorcontrib>ZHU LIYUN</creatorcontrib><title>Medicine for treating doxorubicin-induced cardiotoxic injury and application</title><description>The invention provides a medicine for treating doxorubicin-induced cardiotoxic injury and application, and relates to the technical field of biological medicine. The invention provides application of a reagent for interfering expression of circular RNAcirc-ZNF609 in myocardial tissue in preparation of a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury, the reagent or the medicine can deliver a gene sequence of circ-ZNF609shRNA which is artificially designed into the myocardial tissue based on AAV virus, and the reagent or the medicine can be used for preparing a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury. The application has the effects of inhibiting apoptosis of myocardial cells, improving the systolic function of the heart and resisting doxorubicin-induced cardiac toxic injury by inhibiting apoptosis of the circular RNAcirc-ZNF609 in myocardial tissues and interfering expression of the circular RNAcirc-ZNF609 in the myocardial tissues.
本发明提供了</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQAK-xEPUP6wMCBhOxlaBYqJV9WPc2YSXsHpc7iL9XwQdYTTEzc3e5shcSZegsQoqMSbQHb5PF_PiaQtRnYg-E0Yslm4RA9JnjC1A9YAiD0GczXbpZh8PIqx8Xbn063ptzwcFaHgMSK6e2uZVlVW-qXb0_bP9p3u_sNoo</recordid><startdate>20220517</startdate><enddate>20220517</enddate><creator>XIAO JUNJIE</creator><creator>WANG LIJUN</creator><creator>SHEN KETING</creator><creator>QI WEITONG</creator><creator>ZHU LIYUN</creator><scope>EVB</scope></search><sort><creationdate>20220517</creationdate><title>Medicine for treating doxorubicin-induced cardiotoxic injury and application</title><author>XIAO JUNJIE ; WANG LIJUN ; SHEN KETING ; QI WEITONG ; ZHU LIYUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114504658A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XIAO JUNJIE</creatorcontrib><creatorcontrib>WANG LIJUN</creatorcontrib><creatorcontrib>SHEN KETING</creatorcontrib><creatorcontrib>QI WEITONG</creatorcontrib><creatorcontrib>ZHU LIYUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XIAO JUNJIE</au><au>WANG LIJUN</au><au>SHEN KETING</au><au>QI WEITONG</au><au>ZHU LIYUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Medicine for treating doxorubicin-induced cardiotoxic injury and application</title><date>2022-05-17</date><risdate>2022</risdate><abstract>The invention provides a medicine for treating doxorubicin-induced cardiotoxic injury and application, and relates to the technical field of biological medicine. The invention provides application of a reagent for interfering expression of circular RNAcirc-ZNF609 in myocardial tissue in preparation of a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury, the reagent or the medicine can deliver a gene sequence of circ-ZNF609shRNA which is artificially designed into the myocardial tissue based on AAV virus, and the reagent or the medicine can be used for preparing a medicine for preventing and/or treating doxorubicin-induced cardiotoxic injury. The application has the effects of inhibiting apoptosis of myocardial cells, improving the systolic function of the heart and resisting doxorubicin-induced cardiac toxic injury by inhibiting apoptosis of the circular RNAcirc-ZNF609 in myocardial tissues and interfering expression of the circular RNAcirc-ZNF609 in the myocardial tissues.
本发明提供了</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN114504658A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Medicine for treating doxorubicin-induced cardiotoxic injury and application |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A31%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XIAO%20JUNJIE&rft.date=2022-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114504658A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |